LUNG CLUSTER SEC Filing Analysis

Latest settled — T+5d ⚠ clustered

LUNG ▼ -12.35% at T+5d

NEUTRAL call ✗ call lost -12.35% · α vs SPY -9.79% · entry $1.62 → $1.42

Next anchor: T+20d in 11d

Last close $1.28 (close Jun 18) · -20.99% from $1.62 entry

Entry anchored
Jun 3, 03:59 PM ET
via Databento tick

T+1d

-5.56%

call -5.56% · α -2.97%

$1.53

settled 17d ago

T+5d

-12.35%

call -12.35% · α -9.79%

$1.42

settled 11d ago

T+20d

—

call — · α —

—

in 11d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Pulmonx Corp (LUNG) insiders filed 6 trades in an 8-day window: 4 non-cash grant/withhold events (zero economic value) plus 2 open-market sales totaling ~$34K. CEO Glendon French sold $21K worth — a modest amount for a $63M market cap. Sales are small in absolute terms and routine in pattern, not signaling material deterioration.

Key Financial Metrics

Direction

selling

Total Value

$34.0K

Insiders

4

Actionable Insight

Pulmonx Corp (LUNG) insiders filed 6 trades in an 8-day window: 4 non-cash grant/withhold events (zero economic value) plus 2 open-market sales totaling ~$34K. CEO Glendon French sold $21K worth — a modest amount for a $63M market cap. Sales are small in absolute terms and routine in pattern, not signaling material deterioration.

Key Facts

4 insiders received restricted stock grants totaling 80,000 shares at $0 — non-cash events
CEO Glendon French sold 13.5K shares for ~$21K at $1.57
General Counsel David Lehman sold 3.9K shares for ~$6K
Total open-market sales value: ~$34K (0.05% of $63M market cap)
No insider open-market purchases in the window

Financial Impact

Open-market sales of ~$34K represent 0.05% of market cap — trivial in size

dilution (grants modestly increase share count)

Risk Factors

CEO selling is modest but there are zero insider purchases to signal confidence
Historical model reads on LUNG have been negative at T+20 avg -4.8%
Sub-$70M micro-cap with analyst consensus 73% bullish — potential for disappointment

Market Snapshot

Exchange

Nasdaq

Sector

Surgical & Medical Instruments & Apparatus

Analyst Consensus

73% bullish (11 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CLUSTER Data (Synthetic)	cluster-LUNG-1781042083837

8 reports for LUNG

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for LUNG — sortable, filterable
	Type				Now
Jun 3, 2026 17d ago	Insider Cluster NEUTRAL ★ 2/10	$1.62 $1.42	▼ −12.35%	▼ −9.79%	$1.28 (−20.99%)
Jun 3, 2026 17d ago	Insider Cluster NEUTRAL ★ 4/10	$1.62 $1.42	▼ −12.35%	▼ −9.79%	$1.28 (−20.99%)
Apr 22, 2026 8w ago	DEFA14A NEUTRAL ★ 3/10	$1.28 $1.20	▼ −6.25%	▼ −7.73%	$1.28 (−0.00%)
Apr 15, 2026 9w ago	Press Release NEUTRAL ★ 3/10	$1.46 $1.28	▼ −12.33%	▼ −13.31%	$1.28 (−12.33%)
Mar 5, 2026 15w ago	8-K BEARISH ★ 7/10	$1.61 $1.78	▼ −10.56%	▼ −12.80%	$1.28 (+20.50%)
Mar 4, 2026 15w ago	8-K MIXED ★ 6/10	$1.61 $1.78	▲ +10.56%	▲ +12.80%	$1.28 (−20.50%)
Mar 4, 2026 15w ago	Press Release MIXED ★ 6/10	$1.61 $1.78	▲ +10.56%	▲ +12.80%	$1.28 (−20.50%)
Mar 2, 2026 15w ago	Insider Cluster NEUTRAL ★ 2/10	$1.53 $1.82	▲ +19.34%	▲ +20.55%	$1.28 (−16.07%)

US Market Status

Market Closed — Opens Mon (29h 34m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access